Subcellular targeting strategies for protein and peptide delivery
- PMID: 38964543
- DOI: 10.1016/j.addr.2024.115387
Subcellular targeting strategies for protein and peptide delivery
Abstract
Cytosolic delivery of proteins and peptides provides opportunities for effective disease treatment, as they can specifically modulate intracellular processes. However, most of protein-based therapeutics only have extracellular targets and are cell-membrane impermeable due to relatively large size and hydrophilicity. The use of organelle-targeting strategy offers great potential to overcome extracellular and cell membrane barriers, and enables localization of protein and peptide therapeutics in the organelles. Although progresses have been made in the recent years, organelle-targeted protein and peptide delivery is still challenging and under exploration. We reviewed recent advances in subcellular targeted delivery of proteins/peptides with a focus on targeting mechanisms and strategies, and highlight recent examples of active and passive organelle-specific protein and peptide delivery systems. This emerging platform could open a new avenue to develop more effective protein and peptide therapeutics.
Keywords: Cancer therapy; Cytosolic delivery; Enzyme-instructed self-assembly; Organelle-targeted delivery; Peptides delivery; Reversible assembly.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly.Adv Drug Deliv Rev. 2024 Jun;209:115327. doi: 10.1016/j.addr.2024.115327. Epub 2024 May 3. Adv Drug Deliv Rev. 2024. PMID: 38703895 Review.
-
Intracellular sequestration of HER2 via targeted subcellular peptide delivery.J Drug Target. 2018 Nov;26(9):840-844. doi: 10.1080/1061186X.2018.1450411. Epub 2018 Mar 20. J Drug Target. 2018. PMID: 29521129
-
Future of nanotherapeutics: Targeting the cellular sub-organelles.Biomaterials. 2016 Aug;97:10-21. doi: 10.1016/j.biomaterials.2016.04.026. Epub 2016 Apr 26. Biomaterials. 2016. PMID: 27155363 Review.
-
Intracellular delivery of nanocarriers and targeting to subcellular organelles.Expert Opin Drug Deliv. 2016;13(1):49-70. doi: 10.1517/17425247.2015.1086745. Epub 2015 Sep 11. Expert Opin Drug Deliv. 2016. PMID: 26358656 Review.
-
Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.Mol Pharm. 2016 Jan 4;13(1):1-7. doi: 10.1021/acs.molpharmaceut.5b00697. Epub 2015 Dec 2. Mol Pharm. 2016. PMID: 26587994
Cited by
-
Barcoded screening identifies nanocarriers for protein delivery to kidney.Nat Commun. 2025 Jan 21;16(1):899. doi: 10.1038/s41467-025-56257-3. Nat Commun. 2025. PMID: 39837887 Free PMC article.
-
Advances in Cytosolic Delivery of Proteins: Approaches, Challenges, and Emerging Technologies.Chem Biodivers. 2025 Jun;22(6):e202401713. doi: 10.1002/cbdv.202401713. Epub 2025 Feb 17. Chem Biodivers. 2025. PMID: 39921680 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources